, Jennifer Landrigan Patnaik
Department of Ophthalmology, University of Colorado School of Medicine, Aurora, CO, USA
© 2019, Korea Health Personnel Licensing Examination Institute
This is an open-access article distributed under the terms of the Creative Commons Attribution License (http://creativecommons.org/licenses/by/4.0/), which permits unrestricted use, distribution, and reproduction in any medium, provided the original work is properly cited.
Authors’ contributions
Conceptualization: CG, JP. Data curation: CG, JP. Formal analysis: CG, JP. Funding acquisition: none. Methodology: CG, JP. Project administration: CG, JP. Visualization: CG, JP. Writing–original draft: CG, JP. Writing–review & editing: CG, JP.
Conflict of interest
No potential conflict of interest relevant to this article was reported.
Funding
This work was supported by a Challenge Grant to the Department of Ophthalmology from Research to Prevent Blindness, Inc. and the Frederic C. Hamilton Macular Degeneration Center and the Colorado Clinical & Translational Sciences Institute (CCSTI) with the Development and Informatics Service Center (DISC) from NIH/NCRR grant number UL1 TR002535.
| Characteristic | All respondents | Family medicine | Internal medicine | Emergency medicine | P-valuea) |
|---|---|---|---|---|---|
| No. of respondents | 1,025 (100.0) | 271 (26.4) | 412 (40.2) | 342 (33.4) | |
| Hours in residency dedicated to ophthalmology | <0.001 | ||||
| 0–10 | 809 (79.9) | 202 (74.5) | 380 (92.5) | 227 (66.8) | |
| 11–20 | 103 (10.0) | 17 (6.3) | 19 (4.6) | 67 (19.7) | |
| 21–30 | 33 (3.2) | 14 (5.2) | 2 (0.5) | 17 (5.0) | |
| 31–40 | 27 (2.6) | 12 (4.4) | 4 (1.0) | 11 (3.2) | |
| >40 | 50 (4.9) | 26 (9.6) | 6 (1.5) | 18 (5.3) | |
| Not answered | 3 (0.3) | ||||
| Patients presenting with ocular complaints (%) | <0.001 | ||||
| <1 | 273 (26.6) | 72 (26.6) | 144 (35.0) | 57 (16.7) | |
| 1–5 | 680 (66.3) | 178 (65.7) | 243 (59.1) | 259 (76.0) | |
| >5 | 70 (6.8) | 21 (7.8) | 24 (5.8) | 25 (7.3) | |
| Not answered | 2 (0.2) |
| Characteristic | No. of study population (%) |
|---|---|
| Total | 1,025 (100.0) |
| Gender | |
| Male | 528 (51.5) |
| Female | 476 (46.5) |
| Not answered | 21 (2.0) |
| Race/ethnicity | |
| White | 601 (58.6) |
| Hispanic | 72 (7.0) |
| African-American | 26 (2.5) |
| Asian/Pacific Islander | 174 (17.0) |
| Native American | 3 (0.3) |
| Multiple race/ethnicities | 35 (3.4) |
| Other | 74 (7.2) |
| Not answered | 40 (3.9) |
| Residency program | |
| Family medicine | 271 (26.4) |
| Internal medicine | 412 (40.2) |
| Emergency medicine | 342 (33.4) |
| Current year | |
| PGY-1 | 376 (36.7) |
| PGY-2 | 320 (31.2) |
| PGY-3 | 291 (28.4) |
| PGY-4 | 37 (3.6) |
| Not answered | 1 (0.6) |
| Medical school | |
| United States | 794 (77.5) |
| International | 227 (22.2) |
| Not answered | 4 (0.4) |
| Characteristic | All respondents | Family medicine | Internal medicine | Emergency medicine | P-value |
|---|---|---|---|---|---|
| No. of respondents | 1,025 (100.0) | 271 (26.4) | 412 (40.2) | 342 (33.4) | |
| Hours in residency dedicated to ophthalmology | <0.001 | ||||
| 0–10 | 809 (79.9) | 202 (74.5) | 380 (92.5) | 227 (66.8) | |
| 11–20 | 103 (10.0) | 17 (6.3) | 19 (4.6) | 67 (19.7) | |
| 21–30 | 33 (3.2) | 14 (5.2) | 2 (0.5) | 17 (5.0) | |
| 31–40 | 27 (2.6) | 12 (4.4) | 4 (1.0) | 11 (3.2) | |
| >40 | 50 (4.9) | 26 (9.6) | 6 (1.5) | 18 (5.3) | |
| Not answered | 3 (0.3) | ||||
| Patients presenting with ocular complaints (%) | <0.001 | ||||
| <1 | 273 (26.6) | 72 (26.6) | 144 (35.0) | 57 (16.7) | |
| 1–5 | 680 (66.3) | 178 (65.7) | 243 (59.1) | 259 (76.0) | |
| >5 | 70 (6.8) | 21 (7.8) | 24 (5.8) | 25 (7.3) | |
| Not answered | 2 (0.2) |
| Survey question | Total | Family medicine | Internal medicine | Emergency medicine |
|---|---|---|---|---|
| Ophthalmic evaluation | ||||
| Visual acuity | 3.3±1.2 | 3.1±1.2 | 2.9±1.2 | 3.9±1.0 |
| Pupils | 3.8±1.0 | 3.6±1.0 | 3.5±1.1 | 4.3±0.8 |
| Extraocular movements | 4.1±0.9 | 4.1±0.9 | 3.8±1.0 | 4.4±0.7 |
| Confrontational visual fields | 3.0±1.2 | 3.0±1.2 | 2.8±1.2 | 3.4±1.2 |
| Tonometry | 2.1±1.4 | 1.6±1.0 | 1.5±1.0 | 3.3±1.2 |
| Split lamp exam | 1.7±1.0 | 1.6±0.9 | 1.3±0.7 | 2.2±1.1 |
| Direct ophthalmoscope | 1.9±1.0 | 2.1±1.0 | 1.7±0.9 | 1.8±0.9 |
| Fluorescein dye test | 2.6±1.5 | 2.4±1.3 | 1.7±1.1 | 3.9±1.0 |
| External exams | ||||
| Blepharitis | 2.5±1.2 | 2.5±1.2 | 2.2±1.2 | 2.9±1.2 |
| Chalazion | 2.8±1.2 | 2.9±1.2 | 2.5±1.2 | 3.2±1.2 |
| Pre-septal cellulitis | 2.8±1.2 | 2.5±1.1 | 2.4±1.1 | 3.4±1.1 |
| Herpes zoster ophthalmicus | 2.5±1.2 | 2.2±1.1 | 2.2±1.1 | 3.0±1.2 |
| Managing care | ||||
| Conjunctivitis | 3.5±1.0 | 3.6±1.0 | 3.2±1.1 | 3.9±0.9 |
| Scleritis | 2.3±1.1 | 2.2±1.1 | 2.2±1.1 | 2.6±1.1 |
| Pterygium | 2.6±1.4 | 2.4±1.3 | 2.3±1.3 | 3.0±1.4) |
| Subconjunctival hemorrhage | 3.1±1.3 | 3.0±1.3 | 2.7±1.3 | 3.7±1.2 |
| Corneal abrasion | 2.8±1.3 | 2.6±1.1 | 2.2±1.1 | 3.8±1.0 |
| Corneal ulcer | 2.2±1.2 | 1.8±1.0 | 1.7±0.9 | 3.2±1.2 |
| Herpes keratitis | 2.0±1.1 | 1.7±0.9 | 2.9±1.1 | 2.7±1.2 |
| Dry eye | 3.1±1.1 | 3.0±1.1 | 1.6±0.9 | 3.3±1.1 |
| Primary open angle glaucoma | 1.9±1.0 | 1.7±0.8 | 1.6±0.9 | 2.3±1.0 |
| Angle closure glaucoma | 2.0±1.1 | 1.7±0.9 | 1.6±0.9 | 2.8±1.2 |
| Cataract | 2.4±1.2 | 2.2±1.1 | 2.3±1.2 | 2.6±1.2 |
| Diabetic retinopathy | 2.2±1.1 | 2.2±1.0 | 2.4±1.1 | 2.0±1.0 |
| Hypertensive retinopathy | 2.1±1.0 | 2.0±1.0 | 2.3±1.1 | 2.0±1.0 |
| Thyroid eye disease | 1.7±1.0 | 1.6±0.9 | 1.8±1.0 | 1.7±1.0 |
| Rheumatologic disease | 1.6±0.9 | 1.5±0.8 | 1.7±0.9 | 1.6±0.8 |
| Sjögren syndrome | 1.8±0.9 | 1.8±0.9 | 1.9±1.0 | 1.7±0.9 |
| Indications for medication | ||||
| Topical antibiotics | 2.7±1.1 | 2.7±1.1 | 2.2±1.0 | 3.1±1.1 |
| Topical steroids | 2.1±1.0 | 2.2±1.1 | 1.9±1.0 | 2.3±1.0 |
| Topical glaucoma meds | 1.9±1.0 | 1.8±0.9 | 1.7±0.9 | 2.3±1.1 |
| Topical nonsteroidal anti-inflammatory drugs | 1.8±1.0 | 1.8±1.0 | 1.6±0.9 | 2.1±1.0 |
| Composite score | ||||
| Average across all 32 | 2.5±0.7 | 2.3±0.6 | 2.2±0.7 | 2.9±0.7 |
| Family medicine | Internal medicine | Emergency medicine | |
|---|---|---|---|
| Hours in residency dedicated to ophthalmology | |||
| 0–10 | 2.3±0.6 | 2.2±0.7 | 2.8±0.7 |
| 11–40 | 2.4±0.6 | 2.4±0.6 | 3.1±0.6 |
| >40 | 3.0±0.8 | 3.0±0.9 | 3.3±0.6 |
| ANOVA P-value | <0.001 | 0.005 | <0.001 |
| Current year | |||
| PGY-1 | 2.2±0.6 | 2.2±0.7 | 2.6±0.6 |
| PGY-2 | 2.3±0.6 | 2.1±0.6 | 3.0±0.6 |
| PGY-3 | 2.5±0.6 | 2.3±0.7 | 3.1±0.6 |
| PGY-4 | 2.9±0.4 | 2.4±0.7 | 3.2±0.6 |
| ANOVA P-value | 0.008 | 0.05 | <0.001 |
PGY, postgraduate year.
Values are presented as number (%). By chi-square test.
Values are presented as mean±standard deviation. Analysis of variance P-values <0.001 across type of residency for each of the 32 ophthalmic measures and the composite score.
Values are presented as mean±standard deviation. ANOVA, analysis of variance; PGY, postgraduate year.